1 / 8

NIHR CLAHRC Leeds York & Bradford

NIHR CLAHRC Leeds York & Bradford. Carl Thompson, Dept. of Health Sciences. CLAHRC?. Collaborations for Leadership in Applied Health Research and Care NHS academic partnerships 9 nationally Nationally £90m (+ £90m NHS) Lybra £10m NIHR, £10m NHS 5 years (till Sep 13)

stian
Download Presentation

NIHR CLAHRC Leeds York & Bradford

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NIHR CLAHRCLeeds York & Bradford Carl Thompson, Dept. of Health Sciences

  2. CLAHRC? • Collaborations for Leadership in Applied Health Research and Care • NHS academic partnerships • 9 nationally • Nationally £90m (+ £90m NHS) • Lybra £10m NIHR, £10m NHS • 5 years (till Sep 13) • research and development

  3. why CLAHRCS? Policy Sir David Cooksey’s translational “2nd Gap” High Level Group on Clinical Effectiveness (Prof Sir John Tooke) “harnessing the capacities of academia”

  4. why CLAHRCs? “the patch” 2.5m people, 55,000 NHS staff, £3.5b health spend per year… clinical effectiveness?? Hospital admission as marker for unmet need: stroke

  5. CLAHRC: the work CLAHRC central @ Leeds director, business planning, IP support 3 research themes • Addiction (Prof. Chris Godfrey, York) • Child and maternal health (Prof. John Wright, Bradford Hospitals and Dr Kate Pickett, York) • “Improve-PC” (cardiovascular disease) (Prof. Alan House, Leeds & Prof. Bob Lewin, York) 2 implementation themes • Information for Stroke Care (Prof. John Young, Bradford NHS) • “trip-lab” (Dr Carl Thompson, York)

  6. trip-lab: the questions • How does time impact on adoption, sustainability, and behavioural change? • What impact do innovation characteristics have on adoption, sustainability, and behavioural change? • What impact do organisational characteristics have on adoption, sustainability, and behavioural change? • Does knowledge of the characteristics of the organisation and teams predict innovation adoption over time?

  7. trip-lab: how? • “Diffusion of innovation” based development, implementation and evaluation • Maternal depression • Mental health (NICE ‘big 8’) • Stroke • Influencing commissioning via knowledge translation • Prediction without costs of RCTs

  8. York Carl Thompson Paul Wilson Ian Watt Simon Gilbody Russell Mannion Nigel Rice Kate Farley Andria Hanbury Duncan Chambers Mona Kanaan Trevor Sheldon Sandy Newby Bradford Dr John Bibby (Dep. Med Director PCT) Erica Warren Heather Sharpe Admin support 75% of P.A.C.E. LPFT Clinical effectiveness director 2 x clinical effectiveness staff Leeds NHS Clinical effectiveness team trip-lab:the team = NIHR (£2m) = NHS (£2m)

More Related